What are the diagnostic tests and treatment options for tick-borne illnesses, such as Lyme disease (LD), ehrlichiosis, and anaplasmosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diagnostic tests for tick-borne illnesses, such as Lyme disease, ehrlichiosis, and anaplasmosis, include blood tests like ELISA and Western blot for Lyme disease, and PCR testing for ehrlichiosis and anaplasmosis, with treatment typically involving antibiotics, specifically doxycycline (100mg twice daily for 10-21 days) as the first-line treatment for all three conditions. The diagnosis of Lyme disease can be made without laboratory testing in patients with a lesion consistent with erythema migrans and a history of exposure to Lyme-endemic areas 1. However, for other manifestations of Lyme disease, laboratory testing is necessary to confirm the diagnosis, using a 2-tiered serologic analysis consisting of an enzyme-linked immunoassay or immunofluorescence assay, followed by reflexive immunoblotting 1.

For ehrlichiosis and anaplasmosis, diagnosis is typically made using PCR testing, and treatment should be initiated promptly, with doxycycline being the drug of choice for treatment of all tickborne rickettsial diseases in children and adults 1. The recommended dosage for doxycycline is 100 mg twice per day, orally or IV, for at least 3 days after fever subsides and until evidence of clinical improvement is noted, with a minimum treatment course of 5–7 days 1.

Some key points to consider in the management of tick-borne illnesses include:

  • Early diagnosis and treatment are crucial to prevent complications
  • Blood tests may be negative in early infection, so treatment is often started based on symptoms and exposure history
  • Patients should remove attached ticks properly using fine-tipped tweezers, grasping close to the skin and pulling upward with steady pressure
  • Prevention includes using insect repellent, wearing protective clothing, checking for ticks after outdoor activities, and promptly removing any attached ticks
  • These infections can cause serious complications if left untreated, including neurological problems, joint issues, and in rare cases, death from ehrlichiosis or anaplasmosis.

It's also important to note that patients with evidence of organ dysfunction, severe thrombocytopenia, mental status changes, or the need for supportive therapy should be hospitalized, and certain patients with tickborne rickettsial disease can be treated on an outpatient basis with oral medication, particularly if a reliable caregiver is available in the home and the patient adheres to follow-up medical care 1.

From the FDA Drug Label

To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria Doxycycline is indicated for the treatment of the following infections: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae. Relapsing fever due to Borrelia recurrentis.

The diagnostic tests and treatment options for tick-borne illnesses are not fully described in the provided drug label. However, doxycycline is indicated for the treatment of:

  • Rocky Mountain spotted fever
  • Tick fevers caused by Rickettsiae
  • Relapsing fever due to Borrelia recurrentis The label does not provide information on the diagnostic tests for these conditions. 2

From the Research

Diagnostic Tests for Tick-Borne Illnesses

  • The diagnosis of tick-borne illnesses, such as Lyme disease, ehrlichiosis, and anaplasmosis, can be challenging due to the nonspecific nature of the symptoms 3.
  • A combination of clinical findings, laboratory tests, and epidemiological information can aid in the diagnosis of these illnesses 4.
  • Characteristic skin changes, such as erythema migrans in Lyme disease, can serve as important diagnostic clues 5.
  • Laboratory tests, such as serology and PCR, can help confirm the diagnosis, but treatment should not be delayed for laboratory confirmation 6.

Treatment Options for Tick-Borne Illnesses

  • Doxycycline or tetracycline is indicated for the treatment of Rocky Mountain spotted fever, Lyme disease, ehrlichiosis, and relapsing fever 6.
  • Empiric treatment with doxycycline is recommended for patients with high clinical suspicion of Rocky Mountain spotted fever, including pregnant women and children 4.
  • Prophylactic treatment after tick exposure in patients without symptoms is generally not recommended, but may be considered within 72 hours of tick removal in specific patients at high risk of Lyme disease 4.
  • Early diagnosis and appropriate antibiotic therapy can lead to greatly improved outcomes for patients with tick-borne illnesses 5.

Prevention of Tick-Borne Illnesses

  • Advising patients about prevention of tick bites, especially in the summer months, can help prevent exposure to dangerous vector-borne diseases 6.
  • Counseling patients on the use of protective clothing and tick repellents during outdoor activities can help minimize the risk of infection 4.
  • Avoidance of tick bites is the most effective way to prevent tick-borne illnesses, and patients at risk for tick bites may be coinfected with two or more tick-borne pathogens 5, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tick-Borne Illnesses.

Current sports medicine reports, 2016

Research

Tickborne Diseases: Diagnosis and Management.

American family physician, 2020

Research

Tick-borne disease.

American family physician, 2005

Research

Lyme Disease Coinfections in the United States.

Clinics in laboratory medicine, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.